Novel Pyrazolopyridine Inhibitors of Monoacylglycerol Lipase for the Treatment of Neurodegenerative Diseases and Neuroinflammation

被引：1
|
作者：
Rosse, Gerard [1 ]
机构：
[1] Arrival Discovery LLC, San Diego, CA 92128 USA
来源：
ACS MEDICINAL CHEMISTRY LETTERS | 2024年 / 15卷 / 01期
关键词：
D O I：
10.1021/acsmedchemlett.3c00548
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
This work highlights the use of bicyclic heterocyclic compounds as monoacylglycerol lipase inhibitors potentially in the treatment of Alzheimer's disease, Parkinson's disease, ALS, traumatic brain injury, and multiple sclerosis.
引用
收藏
页码：19 / 20
页数：2
相关论文
共 50 条
  • [1] Identification of potent and selective covalent monoacylglycerol lipase (MAGL) inhibitors for treatment of neuroinflammation
    McAllister, Laura
    Beck, Elizabeth
    Brodney, Michael
    Butler, Christopher
    Gilbert, Adam
    Harris, Anthony
    Helal, Christopher
    Johnson, Douglas
    Mente, Scot
    Montgomery, Justin
    O'Neil, Steven
    Piro, Justin
    Rogers, Bruce
    Samad, Tarek
    Webb, Damien
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [2] Novel Heterocyclic Compounds as Monoacylglycerol Lipase Inhibitors for Treating Multiple Diseases
    Sabnis, Ram W.
    ACS MEDICINAL CHEMISTRY LETTERS, 2024, : 994 - 995
  • [3] Inhibitors of monoacylglycerol lipase as novel analgesics
    Hohmann, A. G.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 150 (06) : 673 - 675
  • [4] Targeting Monoacylglycerol Lipase in Pursuit of Therapies for Neurological and Neurodegenerative Diseases
    Zanfirescu, Anca
    Ungurianu, Anca
    Mihai, Dragos Paul
    Radulescu, Denise
    Nitulescu, George Mihai
    MOLECULES, 2021, 26 (18):
  • [5] Discovery of Trifluoromethyl Glycol Carbamates as Potent and Selective Covalent Monoacylglycerol Lipase (MAGL) Inhibitors for Treatment of Neuroinflammation
    McAllister, Laura A.
    Butler, Christopher R.
    Mente, Scot
    O'neil, Steven, V
    Fonseca, Kari R.
    Piro, Justin R.
    Cianfrogna, Julie A.
    Foley, Timothy L.
    Gilbert, Adam M.
    Harris, Anthony R.
    Helal, Christopher J.
    Johnson, Douglas S.
    Montgomery, Justin, I
    Nason, Deane M.
    Noell, Stephen
    Pandit, Jayvardhan
    Rogers, Bruce N.
    Samad, Tarek A.
    Shaffer, Christopher L.
    da Silva, Rafael G.
    Uccello, Daniel P.
    Webb, Damien
    Brodney, Michael A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (07) : 3008 - 3026
  • [6] Discovery of a novel class of reversible monoacylglycerol lipase inhibitors for potential treatment of depression
    Hao, Qingjing
    Shi, Junwei
    Zhang, Zhilan
    Yang, Guoqing
    Zhi, Yunbao
    Wang, Ke
    Ma, Dingchen
    Fu, Shengnan
    Dong, Haijuan
    Zhi, Zhuoer
    Zhang, Wenting
    Li, Tingting
    Wang, Jinxin
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 268
  • [7] Antifibrogenic properties of monoacylglycerol lipase inhibitors
    Habib, Aida
    Wan, Jinghong
    Hegde, Pushpa
    Weiss, Emmanuel
    Brouillet, Arthur
    Moreau, Richard
    Lotersztajn, Sophie
    HEPATOLOGY, 2015, 62 : 891A - 891A
  • [8] Therapeutic potential of monoacylglycerol lipase inhibitors
    Mulvihill, Melinda M.
    Nomura, Daniel K.
    LIFE SCIENCES, 2013, 92 (8-9) : 492 - 497
  • [9] DEVELOPMENT OF MONOACYLGLYCEROL LIPASE (MGL) INHIBITORS
    Ortega-Gutierrez, Silvia
    Cisneros, Jose A.
    Hu, Janling
    Fowler, Christopher J.
    Lopez-Rodriguez, Maria L.
    DRUGS OF THE FUTURE, 2009, 34 : 214 - 214
  • [10] Neuroinflammation and immunometabolism in neurodegenerative diseases
    Lonkar, Neha
    Latz, Eicke
    Mcmanus, Roisin M.
    CURRENT OPINION IN NEUROLOGY, 2025, 38 (02) : 163 - 171
12345